ACTA1 and metabolic disease: By regulating the expression of related genes, PPARG can correct liver lipid metabolism disorders, reduce oxidative stress, reduce the fibrotic cytokine α-smooth muscle actin (α-SMA) in HSCs and is essential for both adipocyte differentiation and HSC quiescence41–43.